- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02667184
The Effect of a Low FODMAP Oral Nutrition Supplement On Breath Hydrogen Response In Healthy Human Subjects
January 30, 2017 updated by: University of Minnesota
The Effect of a Low FODMAP Oral Nutrition Supplement On Breath Hydrogen Response In Health Human Subjects
The goal of this study is to determine subjective gastrointestinal tolerance response and differences in breath hydrogen response following the consumption of different types of low FODMAP oral nutrition supplements.
This randomized, crossover study requires participants to arrive to the lab 12 hours fasted, consume an oral liquid supplement and complete gastrointestinal tolerance questionnaires as well as produce samples for breath hydrogen analysis at various time points over a 4 hour time period.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This randomized, crossover study requires participants to arrive to the lab 12 hours fasted, consume an oral liquid supplement and complete gastrointestinal tolerance questionnaires as well as produce samples for breath hydrogen and methane analysis at various time points over a 4 hour time period.
Subjects will also be asked to rate gastrointestinal symptoms via a questionnaire at various time points throughout the study.
Study Type
Interventional
Enrollment (Actual)
21
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Minnesota
-
St. Paul, Minnesota, United States, 55108
- University of Minnesota
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Between the ages of 18-65 years with a body mass index between 18-29 kg/m2.
- Demonstrates spoken and written English literacy and able to provide written, informed consent after review of study protocol and procedures.
Exclusion Criteria:
- Use of enemas, proton pump inhibitors, or antibiotics within the past 3 months
- Smoker
- Not a regular breakfast eater
- Self-reported history of a past or current gastrointestinal disease
- High fiber eater (> or = to 3 servings of high fiber foods per day)
- Concurrent or recent (within 30 days) participation in an intervention trial
- Recent weight fluctuations
- Allergies to any of the test products
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Low FODMAP Oral Nutrition Supplement 1
Low FODMAP Oral Nutrition Supplement
|
|
|
Experimental: Low FODMAP Oral Nutrition Supplement 2
Low FODMAP Oral Nutrition Supplement
|
|
|
Experimental: Low FODMAP Oral Nutrition Supplement 3
Low FODMAP Oral Nutrition Supplement
|
|
|
Experimental: FOS Supplement
Supplement containing fructooligosaccharides
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Breath hydrogen response
Time Frame: baseline
|
At baseline, subjects will be asked to exhale a full breath into a sample collection bag.
The breath samples will be extracted and measured using the Quintron Breath Track Analyzer.
This will be a marker of carbohydrate fermentation in the colon.
|
baseline
|
|
Breath hydrogen response
Time Frame: 60 minutes
|
At 60 minutes, subjects will be asked to exhale a full breath into a sample collection bag.
The breath samples will be extracted and measured using the Quintron Breath Track Analyzer.
This will be a marker of carbohydrate fermentation in the colon.
|
60 minutes
|
|
Breath hydrogen response
Time Frame: 120 minutes
|
At 120 minutes, subjects will be asked to exhale a full breath into a sample collection bag.
The breath samples will be extracted and measured using the Quintron Breath Track Analyzer.
This will be a marker of carbohydrate fermentation.
|
120 minutes
|
|
Breath hydrogen response
Time Frame: 240 minutes
|
At 240 minutes, subjects will be asked to exhale a full breath into a sample collection bag.
The breath samples will be extracted and measured using the Quintron Breath Track Analyzer.
This will be a marker of carbohydrate fermentation.
|
240 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Gastrointestinal tolerance
Time Frame: 48 hours
|
Subjects will answer a 7 symptom questionnaire regarding the intensity of gastrointestinal symptoms experienced following consumption of each of the supplements.
Questionnaire is adapted from the validated Bovenshen gastrointestinal tolerance questionnaire.
Questionnaire is to be completed at baseline, 30 min, 60 min, 90 min, 120 min, 180 min, 12 hours, 24 and 48 hours.
|
48 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2016
Primary Completion (Actual)
June 1, 2016
Study Completion (Actual)
June 1, 2016
Study Registration Dates
First Submitted
January 15, 2016
First Submitted That Met QC Criteria
January 25, 2016
First Posted (Estimate)
January 28, 2016
Study Record Updates
Last Update Posted (Estimate)
January 31, 2017
Last Update Submitted That Met QC Criteria
January 30, 2017
Last Verified
January 1, 2017
More Information
Terms related to this study
Other Study ID Numbers
- 1507E75043
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Food Selection
-
University of California, DavisCompleted
-
Texas Christian UniversityCompleted
-
University of MinnesotaCompleted
-
University of MinnesotaGeneral MillsCompleted
-
University of MinnesotaCompleted
-
Kathmandu University School of Medical SciencesResolve to Save LivesRecruiting
-
Johns Hopkins Bloomberg School of Public HealthNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University... and other collaboratorsCompleted
-
The University of Hong KongCompleted
-
Stanford UniversityNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
Laval UniversityMinistère de l'environnement et lutte contre les changements climatiquesCompleted
Clinical Trials on Low FODMAP Oral Nutrition Supplement
-
Universitat de LleidaLactalisRecruitingGlucose Metabolism DisordersSpain
-
Peking University Cancer Hospital & InstituteZhejiang Cancer Hospital; Shanxi Province Cancer Hospital; The First Affiliated... and other collaboratorsUnknownEsophageal CancerChina
-
Oslo University HospitalCompletedIrritable Bowel Syndrome | Diet Modification | Celiac Disease | Gluten SensitivityNorway
-
Beni-Suef UniversityCompleted
-
Société des Produits Nestlé (SPN)Completed
-
Pierre SingerCompletedMalnourished | HospitalizedIsrael
-
Société des Produits Nestlé (SPN)Completed
-
Wageningen University and ResearchFonterra (Europe) Cooperatie U.A.CompletedSensory Evaluation | Perceived SatietyNetherlands
-
Istanbul Medipol University HospitalMedipol UniversityNot yet recruitingIrritable Bowel Syndrome
-
Oh Yoen KimDong-A UniversityCompleted